Last 12 months
Inside the activity.
4 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2020 Filed Jun 23, 2020 21:50 UTC |
WELLS DAVID BDirector
|
SaleClass A Common Stock | 2,840 | $400.00 | $1,136,000.00 |
DisclosureSEC source: 0001209191-20-038564 · doc4.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,617 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:50 UTC |
WELLS DAVID BDirector
|
Exercise / conversionClass A Common Stock | 2,840 | $54.52 | $154,836.80 |
DisclosureSEC source: 0001209191-20-038564 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:13 UTC |
Yang VivianChief Legal Officer
|
ConversionClass B Common Stock · Derivative | 1,263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037338 · doc4.xml · derivative · entry 5 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F2 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:13 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionClass B Common Stock · Derivative | 1,263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037338 · doc4.xml · derivative · entry 4 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,263 Underlying: Class A Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F2 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:13 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,263 | $0.00 Strike: $18.03 | $0.00 |
DisclosureSEC source: 0001209191-20-037338 · doc4.xml · derivative · entry 3 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,558 Underlying: Class B Common Stock · 1,263 shares Expires 2026-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on August 15, 2016, the Vesting Commencement Date ("VCD"). One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:13 UTC |
Yang VivianChief Legal Officer
|
SaleClass A Common Stock | 1,263 | $370.66 | $468,143.58 |
DisclosureSEC source: 0001209191-20-037338 · doc4.xml · nonDerivative · entry 2 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,045 Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:13 UTC |
Yang VivianChief Legal Officer
|
ConversionClass A Common Stock | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037338 · doc4.xml · nonDerivative · entry 1 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 126 | $372.28 | $46,907.28 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 12 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.09 to $372.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 99 | $369.39 | $36,569.61 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 11 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,126 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.21 to $369.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 127 | $368.35 | $46,780.45 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 10 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,225 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.94 to $368.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 180 | $366.91 | $66,043.80 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 9 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,352 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.67 to $366.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 158 | $365.62 | $57,767.96 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 8 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,532 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.55 to $365.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 101 | $365.02 | $36,867.02 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 7 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,690 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.51 to $365.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 258 | $363.76 | $93,850.08 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 6 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,791 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.49 to $364.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 205 | $362.64 | $74,341.20 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 5 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,049 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.46 to $362.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 62 | $361.62 | $22,420.44 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 4 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,254 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.33 to $361.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 65 | $360.96 | $23,462.40 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 3 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,316 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.24 to $360.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 115 | $353.45 | $40,646.75 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 2 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.84 to $353.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:05 UTC |
Paley Eric BDirector
|
SaleClass A Common Stock | 4 | $345.55 | $1,382.20 |
DisclosureSEC source: 0001209191-20-037321 · doc4.xml · nonDerivative · entry 1 Paley Eric B · CIK 0001670811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,496 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,190 | $0.00 Strike: $142.45 | $0.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · derivative · entry 30 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,330 Underlying: Class A Common Stock · 2,190 shares Expires 2028-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F25 · derivative.exercise_date: The option was granted on December 1, 2018, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,250 | $0.00 Strike: $48.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · derivative · entry 29 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,637 Underlying: Class A Common Stock · 5,250 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F24 · derivative.exercise_date: The option was granted on December 1, 2017, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,220 | $0.00 Strike: $30.15 | $0.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · derivative · entry 28 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,510 Underlying: Class A Common Stock · 3,220 shares Expires 2026-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F23 · derivative.exercise_date: The option was granted on December 23, 2016. The VCD is December 1, 2016. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
ConversionClass B Common Stock · Derivative | 867 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · derivative · entry 27 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 858 Underlying: Class A Common Stock · 867 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F22 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F22 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionClass B Common Stock · Derivative | 867 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · derivative · entry 26 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Underlying: Class A Common Stock · 867 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F22 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F22 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 867 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · derivative · entry 25 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 867 shares Expires 2025-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F21 · derivative.exercise_date: The option was granted on December 9, 2015. The Vesting Commencement Date ("VCD") is January 1, 2016. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 500 | $362.52 | $181,260.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 24 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,208 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.30 to $362.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,499 | $361.68 | $542,158.32 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 23 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.24 to $362.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,100 | $360.87 | $396,957.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 22 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,207 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.21 to $361.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,100 | $359.52 | $395,472.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 21 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,307 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.11 to $359.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 700 | $358.33 | $250,831.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 20 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,407 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.02 to $358.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 600 | $357.45 | $214,470.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 19 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,107 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.00 to $357.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 200 | $355.44 | $71,088.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 18 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,707 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.41 to $355.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,058 | $354.69 | $375,262.02 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 17 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,907 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.28 to $355.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 727 | $353.98 | $257,343.46 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 16 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,965 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.64 to $354.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,463 | $353.01 | $516,453.63 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 15 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,692 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.63 to $353.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionClass A Common Stock | 2,190 | $142.45 | $311,965.50 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 14 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,537 | $352.32 | $541,515.84 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 13 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,965 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.86 to $352.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 2,500 | $351.28 | $878,200.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 12 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,502 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.78 to $351.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,213 | $350.18 | $424,768.34 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 11 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,002 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.78 to $350.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionClass A Common Stock | 5,250 | $48.00 | $252,000.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 10 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 87 | $349.78 | $30,430.86 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 9 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,965 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 2,000 | $349.34 | $698,680.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 8 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,052 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.73 to $349.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 700 | $348.17 | $243,719.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 7 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,052 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.66 to $348.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 433 | $346.85 | $150,186.05 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 6 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,752 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.45 to $347.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionClass A Common Stock | 3,220 | $30.15 | $97,083.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 5 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 267 | $346.06 | $92,398.02 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 4 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,965 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.90 to $346.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 300 | $345.40 | $103,620.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 3 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,232 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.78 to $345.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 300 | $343.92 | $103,176.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 2 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,532 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $343.59 to $344.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 23:30 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
ConversionClass A Common Stock | 867 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037097 · doc4.xml · nonDerivative · entry 1 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:21 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,234 | $0.00 Strike: $263.34 | $0.00 |
DisclosureSEC source: 0001209191-20-036267 · doc4.xml · derivative · entry 3 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,642 Underlying: Class A Common Stock · 1,234 shares Expires 2029-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on December 1, 2019, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.